Social Links

Follow on Facebook Follow on TwitterFollow EiR on PinterestFollow EiR on Instagram

Xpert Access

×

Login To Get Involved!


Forgot your username?


Forgot your password?

×

Join Us At EiR Now!

DNRS Roof Banner

 

DNRS 4th of July Sale! 15% Discount with Code:
DNRSRECOVERY

Universal AJAX Live Search

Search - Categories
Search - Contacts
Search - Content
Search - Newsfeeds
Search - Weblinks

XMRV Update Plus A Possible New Treatment

 

 

 

 

 
Dr. Jacob Teitelbaum

Dr. Jacob Teitelbaum's Column

...expert advice on CFS, Fibromyalgia and other Health Topics.

 

 

 

 

 

 

 

 

 
 
Jacob Teitelbaum MD is Medical Director of the Fibromyalgia and Fatigue Centers
(www.fibroandfatigue.com). Senior author of the landmark studies "Effective Treatment of Chronic Fatigue Syndrome and Fibromyalgia -- a Placebo-controlled Study" & “Effective Treatment of CFS & Fibromyalgia with D-Ribose”. Author of the best-selling book” From Fatigued to Fantastic!”(3rd ed-Penguin/Avery Oct 4, 2007) , " Three Steps to Happiness! Healing through Joy", and “Pain Free 1-2-3- A Proven Program to Get YOU Pain Free! “(McGraw Hill, 2006). He does numerous media appearances, including CNN and FOX National News and is a frequent guest on Oprah and Friends with Dr. Oz.. He lives in Kona, Hawaii. Visit his web site at www.Vitality101.com

 

You can benefit from Dr. Teitelbaum's wisdom and experience by visiting us at The Environmental Illness Resource regularly to read articles from his latest newsletter!

 

 

 

Monday, May 9th, 2011:

 

XMRV Update, Plus — A Possible New TreatmentXMRV Update, Plus — A Possible New Treatment

 

by Jacob Teitelbaum MD

 

 

Dear Readers,

 

A new study is out this week in the Journal of Virology, done by researchers I respect from the University of Utah, Fatigue Consultation Clinic, and ARUP Laboratories. The study was well done and did not find XMRV present in CFS patients. This important study looked at 100 CFS patients and 200 controls. In addition, 14 patients who had positive tests for XMRV at WPI, including two in the original WPI study, also tested negative for XMRV in this study.
 
So what does this all mean? On one level, likely one of two things:

   1. Either it takes the specialized testing done at the WPI to detect the virus, OR
   2. Positive findings in the Mikovits and Alter studies were the result of contamination.
 
What does it not mean that this study did not find XMRV?
 
It does not say anything about whether CFS & fibromyalgia are real. There are many studies showing numerous infections in CFS/FMS, as is expected in an immune disorder. Treating these infections and the immune dysfunction is an important part of treatment (remember, the "I" in SHINE stands for Infections in the "SHINE Treatment Protocol"). The study also does not change treatment at this time, as we do not recommend the AIDS antivirals that might work against XMRV.
 

Some Good News?
 
New research opens some exciting and very novel (and low cost) new possibilities for testing and treatment in CFS!
 
As the study authors note, there is "still a wealth of prior data to encourage further research into the involvement of other infectious agents in CFS, and these efforts must continue."
 
More studies are planned to explore the XMRV virus and CFS. At this point though, what is needed to resolve the debate is what we have been recommending for quite a while (see XMRV Controversy Heats Up — Two Important New Studies), and which would simply and clearly answer whether the XMRV found in the WPI testing is real or a contaminant. An independent group (and the ones who did this study would be an excellent choice) should select people to test. Half of the samples sent to the WPI should be from people with clearcut CFS and half from healthy patients, and the samples should be blinded (i.e., not labeled as to whether they are coming from CFS or healthy control patients). If the samples sent to the WPI clearly again come up positive for XMRV in CFS patients and negative for healthy patients, as in the earlier study, it would immediately answer the question of whether XMRV is more common in CFS or whether it was simply lab error. So in real life, there is really a very simple approach that could answer these questions.
 

A Possible New Treatment?
 
Another recent but largely unnoticed study offers:

   1. A powerful new piece to the puzzle of what is happening in CFS,
   2. The possibility that two simple tests from any lab could help tell which CFS patients have important viral infections, and
   3. A simple, very surprising, and low-cost treatment (the medication is 20 cents a day) that could help fight these infections
 
Though the role of XMRV is still a big question mark, this other possibility is very exciting stuff! I am researching the area further and in the process of writing the article, so I hope to have it an upcoming newsletter in the next few weeks. All I can say is it is very fascinating and promising ;-)
 
Stay tuned!
 
Love & blessings,
 
Dr. T

 

P.S. — You can download a pdf of the XMRV study from Journal of Virology.

 

 

 

 


 

Used with permission from Dr Jacob Teitelbaum's free newsletters-available at www.Vitality101.com

 

 

Learn more from Dr. Teitelbaum's books:

 

 

From Fatigued To Fantastic

 

From Fatigued to Fantastic!: A Proven Program to Regain Vibrant Health, Based on a New Scientific Study Showing Effective Treatment for Chronic Fatigue and Fibromyalgia


Buy from Amazon.com

Buy From Amazon.co.ukXMRV Update Plus A Possible New Treatment

Pain Free 1-2-3

 

Pain Free 1-2-3: A Proven Program for Eliminating Chronic Pain Now!


Buy from Amazon.com

Buy From Amazon.co.ukXMRV Update Plus A Possible New Treatment

 

 


 

 

Related Articles:

 

Mold Testing & Sanitizer:

 

 

 

 

ADVERTISEMENT

 

  • No comments found

Leave your comments

Post comment as a guest

0 Character restriction
Your text should be more than 25 characters
Your comments are subjected to administrator's moderation.
terms and condition.

Adsense Responsive BottomBanner